![](https://tracker.live.rns-distribution.com/track.live-rns/5316271_d9353a075fe0b610698e373da828b7e4.png)
20 August 2024
LendInvest plc
("LendInvest" or the "Company")
Issue of Shares to the Employee Benefit Trust
and
Total Voting Rights
LendInvest plc (AIM: LINV) today announces the proposed issue and allotment of 1,750,000 new ordinary shares in the capital of the Company of £0.0005 each (the "New Shares") intended to be subscribed for at par value by Equiniti Trust (Jersey) Limited (the "Trustee"), as trustee of the LendInvest Employee Benefit Trust (the "EBT"). The EBT is subscribing for the New Shares to satisfy the grant of share awards to employees and the expected exercise of vested share options held by employees under the Company's share plans.
The subscription costs for the New Shares will be funded by way of a loan from the Company to the EBT. The New Shares will rank pari passu in all respects with the Company's existing Ordinary Shares.
Application has been made to London Stock Exchange plc for admission of the New Shares to trading on AIM ("Admission"). It is expected that Admission will become effective on 21 August 2024.
Following Admission, the total number of Ordinary Shares held by the EBT will be 2,467,937 representing approximately 1.7% of the Company's total voting rights.
Following Admission, the total number of shares in issue in the Company will be 142,782,025. The Company does not hold any shares in treasury and all shares have equal voting rights. Therefore, the total number of voting rights in the Company, following Admission, will be 142,782,025. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, LendInvest under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.
For further information, please contact:
LendInvest via Teneo +44 (0)20 7353 4200
Rod Lockhart, Chief Executive Officer
Leigh Rimmer, Director of Communications
investorrelations@lendinvest.com
Panmure Liberum (NOMAD and Sole Broker) +44 (0)20 7886 2500
Atholl Tweedie
Stephen Jones
David Watkins
Teneo (Financial PR) +44 (0)20 7353 4200
Tom Murray
Ed Cropley
Olivia Lucas
IMPORTANT NOTICE
This announcement or any part of it does not constitute or form part of any offer to issue or sell, or the solicitation of an offer to acquire, purchase or subscribe for, any securities in any jurisdiction.
No action has been taken by the Company or any of its affiliates, or any person acting on its or their behalf that would permit an offer of Ordinary Shares or possession or distribution of this announcement or any other offering or publicity material relating to Ordinary Shares in any jurisdiction where action for that purpose is required. Persons into whose possession this announcement comes are required by the Company to inform themselves about, and to observe, such restrictions.
This announcement does not constitute a recommendation concerning any investment decision. Any indication in this announcement of the price at which Ordinary Shares have been bought or sold in the past cannot be relied upon as a guide to future performance. The price of shares and any income expected from them may go down as well as up and investors may not get back the full amount invested upon disposal of the shares. Past performance is no guide to future performance. This announcement does not identify or suggest, or purport to identify or suggest, the risks (direct or indirect) that may be associated with an investment in the Ordinary Shares. The contents of this announcement are not to be construed as legal, business, financial or tax advice.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.